
Interfacing’s IMS is an AI-enabled platform that combines business process modeling, quality management, controlled documentation, and governance/risk capabilities in a single hub. Organizations rely on IMS to document and automate workflows, maintain versioned records, manage risk programs, and keep compliance activities aligned with regulatory requirements through full lifecycle traceability.
Developed for industries where accountability and oversight are essential, including aerospace, pharma/biotech, finance, and government, IMS delivers operational insight, workflow automation, and intelligent recommendations that help reduce risk and improve quality outcomes. The platform holds ISO 27001 certification and includes 21 CFR Part 11 validation, supporting secure use in high-compliance environments. Additional capabilities include low-code app creation, AI-based process mining, audit management, CAPA and training modules, and performance dashboards. AI improves governance accuracy, strengthens compliance posture, and supports ongoing improvement.
Learn more

IONOS provides GPU Servers that create a powerful computing environment tailored for handling tasks requiring much greater power than conventional CPU systems can offer. This setup includes high-quality NVIDIA GPUs, such as the H100, H200, and L40s, alongside dedicated AI accelerators like Intel Gaudi, which support extensive parallel processing for resource-intensive applications. With GPU-accelerated instances, the cloud infrastructure is further improved by integrating dedicated graphical processors, allowing virtual machines to perform complex calculations and manage data-heavy operations considerably more swiftly than standard servers. This solution is particularly advantageous in sectors like artificial intelligence, deep learning, and data science, where it is crucial to train models on large datasets or conduct fast inference processes. Additionally, it supports big data analytics, scientific simulations, and visualization tasks requiring significant computational strength, such as 3D rendering and modeling. Consequently, organizations aiming to enhance their processing power for intricate workloads can reap substantial benefits from this sophisticated infrastructure, making it an ideal choice for modern computational demands. Moreover, the flexibility of this service allows businesses to scale their resources according to project requirements, ensuring efficient performance across various applications.
Learn more
alvaMolecule
alvaMolecule is a no-code cheminformatics platform that enables users to visualize, curate, and standardize molecular datasets in preparation for analytical work. It supports widely-used molecular formats like SMILES and SDF/MOL2, allowing seamless navigation through collections in either grid or spreadsheet views while automatically importing pertinent data. The platform guarantees structure verification and standardization through built-in standardizers and customizable SMIRKS rules, aids in the detection and management of duplicates, and offers scaffold analysis to summarize essential frameworks.
Moreover, it includes integrated filtering and charting features that enable sorting by substructures, calculated molecular descriptors, and various physicochemical properties. alvaMolecule can calculate approximately 88 structural and physicochemical properties, which include drug-like and lead-like scoring metrics such as LogP, TPSA, and the Lipinski alert index, ultimately supporting users in creating high-quality datasets for QSAR/QSPR modeling, descriptor computations, and virtual screening tasks. In addition, its intuitive interface makes it accessible for researchers of all coding skill levels, allowing them to effectively enhance their cheminformatics endeavors and streamline their research processes.
Learn more
Schrödinger
Transform the domains of drug development and materials science by employing advanced molecular modeling approaches. Our computational platform, rooted in the principles of physics, offers distinct solutions for predictive modeling, data analysis, and collaborative efforts, enabling efficient exploration of chemical space. This state-of-the-art platform is utilized by top industries worldwide, supporting drug discovery projects and materials science endeavors in diverse fields such as aerospace, energy, semiconductors, and electronic displays. It propels our internal drug discovery initiatives, managing the entire process from identifying targets to discovering hits and optimizing leads. Moreover, it boosts our collaborative research aimed at developing innovative medicines to tackle major public health issues. With a dedicated team comprising over 150 Ph.D. scientists, we invest considerable resources into research and development. Our impact on the scientific community is highlighted by over 400 peer-reviewed publications that demonstrate the effectiveness of our physics-based approaches, ensuring we remain leaders in the evolution of computational modeling techniques. We are unwavering in our commitment to pioneering advancements and broadening the horizons of our industry while fostering partnerships that amplify our research capabilities.
Learn more